Leczenie w Dobrej Cenie Spółka z Ograniczoną Odpowiedzialnością (KRS 0000653310, NIP 7262663596) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. Leczenie w Dobrej Cenie operates in: Activities of head offices (PKD 70.10.Z). Industry: Consulting and management. The company has been listed in the National Court Register since December 16, 2016. Leczenie w Dobrej Cenie's most recently reported net revenue was 0 PLN for 2024.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Leczenie w Dobrej Cenie
Identity
- Name
- Leczenie w Dobrej Cenie Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- Limited Liability Company (LLC)
- Founded
- December 16, 2016
- Registry status as of
- July 14, 2026
- Latest entry
- July 14, 2026
- Founding act
- 15.12.2016 R.
Articles of association history (1)
- December 15, 2016: 15.12.2016 R.
Activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. ROJNA, 41, 91-134, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Leczenie w Dobrej Cenie
Credibility rating
66.5 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
4
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/10 yrs
Board changes
1
1/10 yrs
PKD changes
0
0/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: C (67/100)
Trend: stable (-0.4 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2024
Current: 10.9 K PLN
Safe: 4.9 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Leczenie w Dobrej Cenie
Founded
December 16, 2016
9 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
70.10.Z
Activities of head offices
Share capital
5.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
5 years
2018–2024 · profitable: 3/5
Registry entries
28
latest: July 14, 2026
Revenue
0 PLN
2024
Net profit
30.2 K PLN
2024
Assets
151.9 K PLN
2024
Equity
104.6 K PLN
2024
Valuation
241.7 K PLN
Low confidence
Low confidence
Board and connected people - Leczenie w Dobrej Cenie
People holding roles at Leczenie w Dobrej Cenie according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
- Andrzej Marcin LisińskiBoard member, Majority shareholder
Directories and rankings for this location
Public procurement
Trademarks
Reviews
Rate business credibility - Leczenie w Dobrej Cenie.
No ratings
Related articles
News
Agora in 2026: return to dividends after 6 years (PLN 0.25), EBITDA of PLN 148m, PLN 200m strategic target
Agora S.A. - the Warsaw-based media holding (Gazeta Wyborcza, the Helios cinema chain, Radio TOK FM and Złote Przeboje, AMS outdoor, Yieldbird) - paid its first dividend in six years (PLN 0.25 per share, PLN 11.65m in total). The 2026–2029 strategy targets a cumulative PLN 2.50 per share in dividends and lifts EBITDA from PLN 148m to PLN 200m.
News
Archicom: a PLN 1.80 per share dividend recommendation after a record 2025 - 2,847 apartments sold, three times the market growth
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.
